Cargando…
Longitudinal Circulating Levels of miR-23b-3p, miR-126-3p and lncRNA GAS5 in HCC Patients Treated with Sorafenib
Human hepatocellular carcinoma (HCC) is the most frequent primary tumor of the liver and the third cause of cancer-related deaths. The multikinase inhibitor sorafenib is a systemic drug for unresectable HCC. The identification of molecular biomarkers for the early diagnosis of HCC and responsiveness...
Autores principales: | Manganelli, Michele, Grossi, Ilaria, Ferracin, Manuela, Guerriero, Paola, Negrini, Massimo, Ghidini, Michele, Senti, Chiara, Ratti, Margherita, Pizzo, Claudio, Passalacqua, Rodolfo, Molfino, Sarah, Baiocchi, Gianluca, Portolani, Nazario, Marchina, Eleonora, De Petro, Giuseppina, Salvi, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301380/ https://www.ncbi.nlm.nih.gov/pubmed/34356875 http://dx.doi.org/10.3390/biomedicines9070813 |
Ejemplares similares
-
Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib
por: Faranda, Teresa, et al.
Publicado: (2019) -
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma
por: Grossi, Ilaria, et al.
Publicado: (2016) -
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2018) -
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC
por: SALVI, ALESSANDRO, et al.
Publicado: (2012) -
miR-126 and miR-126*: New Players in Cancer
por: Meister, Jeannette, et al.
Publicado: (2010)